Magnus Gisslen

Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?
P. D. Burbelo, R. W. Price, Lars Hagberg, H. Hatano, S. Spudich et al.
Journal of Infectious Diseases, Journal article 2018
Journal article

Structural brain abnormalities in successfully treated HIV infection: associations with disease and cerebrospinal fluid biomarkers.
Rosan A Van Zoest, Jonathan Underwood, Davide De Francesco, Caroline A Sabin, James H Cole et al.
The Journal of infectious diseases, Journal article 2018
Journal article

Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy.
Elham Rahimy, Fang-Yong Li, Lars Hagberg, Dietmar Fuchs, Kevin Robertson et al.
The Journal of infectious diseases, Journal article 2017
Journal article

Sensitive, Subtype Independent HIV-1 PCR Assays for Assessment of Residual Viremia and Total HIV-1 DNA
Tomas Mellberg, Jon Krabbe, Maria Buzon, Ulrika Noborg, Magnus Lindh et al.
International Journal of Virology and AIDS, Journal article 2017
Journal article

High Cellular Monocyte Activation in People Living With Human Immunodeficiency Virus on Combination Antiretroviral Therapy and Lifestyle-Matched Controls Is Associated With Greater Inflammation in Cerebrospinal Fluid
T. Booiman, F. W. Wit, I. Maurer, D. De Francesco, C. A. Sabin et al.
Open Forum Infectious Diseases, Journal article 2017
Journal article

Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls.
Aylin Yilmaz, Kaj Blennow, Lars Hagberg, Staffan Nilsson, Richard W Price et al.
Expert review of molecular diagnostics, Journal article 2017
Journal article

Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients
A. Haggblom, M. Santacatterina, U. Neogi, Magnus Gisslén, B. Hejdeman et al.
Plos One, Journal article 2017
Journal article

Recent increased identification and transmission of HIV-1 unique recombinant forms in Sweden
U. Neogi, A. B. Siddik, P. Kalaghatgi, Magnus Gisslén, G. Bratt et al.
Scientific Reports, Journal article 2017
Journal article

No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau).
Jan Jessen Krut, Richard W Price, Henrik Zetterberg, Dietmar Fuchs, Lars Hagberg et al.
Virulence, Journal article 2017
Journal article

Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment
O. Elvstam, P. Medstrand, Aylin Yilmaz, P. E. Isberg, Magnus Gisslén et al.
Plos One, Journal article 2017
Journal article

An example of genetically distinct HIV-1 variants in cerebrospinal fluid and plasma during suppressive therapy.
Viktor Dahl, Magnus Gisslén, Lars Hagberg, Julia Peterson, Wei Shao et al.
The Journal of infectious diseases, Journal article 2014
Journal article

Temporal Trends in the Swedish HIV-1 Epidemic: Increase in Non-B Subtypes and Recombinant Forms over Three Decades.
Ujjwal Neogi, Amanda Häggblom, Michele Santacatterina, Göran Bratt, Magnus Gisslén et al.
PloS one, Journal article 2014
Journal article

Treatment of HIV in the Central Nervous System
Aylin Yilmaz, Magnus Gisslén
Seminars in Neurology, Journal article 2014
Journal article

Evolving Character of Chronic Central Nervous System HIV Infection
Richard W. Price, Serena S. Spudich, Julia Peterson, Sarah Joseph, Dietmar Fuchs et al.
Seminars in Neurology, Journal article 2014
Journal article

Kinetics of Microbial Translocation Markers in Patients on Efavirenz or Lopinavir/r Based Antiretroviral Therapy
J. Vesterbacka, P. Nowak, B. Barqasho, S. Abdurahman, J. Nystrom et al.
PLoS ONE, Journal article 2013
Journal article

Lopinavir/ritonavir, atazanavir/ritonavir, and efavirenz in antiretroviral-naïve HIV-1-infected individuals over 144 weeks: An open-label randomized controlled trial.
Lars-Magnus Andersson, Jan Vesterbacka, Anders Blaxhult, Leo Flamholc, Staffan Nilsson et al.
Scandinavian journal of infectious diseases, Journal article 2013
Journal article

Approach to Cerebrospinal Fluid (CSF) Biomarker Discovery and Evaluation in HIV Infection.
Richard W Price, Julia Peterson, Dietmar Fuchs, Thomas E Angel, Henrik Zetterberg et al.
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, Journal article 2013
Journal article

External Validation of the Bilirubin-Atazanavir Nomogram for Assessment of Atazanavir Plasma Exposure in HIV-1-Infected Patients.
Dinko Rekić, Daniel Röshammar, Martin Bergstrand, Joel Tärning, Andrea Calcagno et al.
The AAPS journal, Journal article 2013
Journal article

Cerebrospinal Fluid and Neuroimaging Biomarker Abnormalities Suggest Early Neurological Injury in a Subset of Individuals During Primary HIV Infection.
Michael J Peluso, Dieter J Meyerhoff, Richard W Price, Julia Peterson, Evelyn Lee et al.
The Journal of infectious diseases, Journal article 2013
Journal article

Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy.
Aylin Yilmaz, Constantin T Yiannoutsos, Dietmar Fuchs, Richard W Price, Kathryn Crozier et al.
Journal of neuroinflammation, Journal article 2013
Journal article